aTyr Pharma ATYR Q1 2026 Earnings Beat Revenue NA EPS 011 Vance Defends Stock Trading Calls for Congressional Ban in Wake of Trump Filings Omnicell OMCL Q1 2026 Earnings Surprise EPS 055 Up Significant Nifty Pharma Index Hits Fresh Peak as Pharma Stocks Rally Up to 7 Strong Earnings and Weaker Rupee Fuel Optimism